Evidence map›Paper›PMID 41257261›Full record

ArticleFrontiers in cardiovascular medicine2025

CHA

Olaf Kądzioła, Konrad Stępień, Alicia Del Carmen Yika, Maria Kurek, Natalia Kachnic, Aleksandra Karcińska, Michael Platschek, Zuzanna Wyleciał, Karol Nowak, Aleksander Siniarski and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Olaf KądziołaDepartment of Coronary Artery Disease and Heart Failure, St. John Paul II Hospital, Kraków, Poland.
Konrad StępieńDepartment of Coronary Artery Disease and Heart Failure, St. John Paul II Hospital, Kraków, Poland.
Alicia Del Carmen YikaStudent Research Group at Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland.
Maria KurekStudent Research Group at Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland.
Natalia KachnicStudent Research Group at Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland.
Aleksandra KarcińskaStudent Research Group at Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland.
Michael PlatschekStudent Research Group at Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland.
Zuzanna WyleciałStudent Research Group at Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland.
Karol NowakDepartment of Coronary Artery Disease and Heart Failure, St. John Paul II Hospital, Kraków, Poland.
Aleksander SiniarskiDepartment of Coronary Artery Disease and Heart Failure, St. John Paul II Hospital, Kraków, Poland.
Jadwiga NesslerDepartment of Coronary Artery Disease and Heart Failure, St. John Paul II Hospital, Kraków, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The mortality rate in decompensated heart failure (HF) with preserved ejection fraction (HFpEF) remains high. In recent years the prognostic role of CHA Methods: 261 (22.74%) out of 1,148 patients included in the single-center Lesser Poland Cracovian Heart Failure (LECRA-HF) Registry between 2009 and 2022 were diagnosed with decompensated HFpEF. We identified 213 (81.61%) subjects with CHA₂DS₂-VASc score ≥4 points and 48 (18.39%) < 4 points. Results: Patients with CHA₂DS₂-VASc ≥4 were older (79 vs. 64 years, Conclusions: As has been shown for the first time CHA

Indexed as

acute decompensated heart failureCHA₂DS₂-VAScheart failure with preserved ejection fractionmortalityprognosisregistryrisk stratification

Identifiers

PMID41257261
PMCPMC12620384

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.